The life of Cipla, the Indian pharma giant, can broadly be divided into three parts: the first 8 decades of altruistic ...

Welcome to the Cipla Stock Liveblog, your ultimate source for real-time updates and analysis of one of the most prominent ...

Prabhudas Lilladher has reduced its Nifty 50 target to 25,689 from 27,172, citing expected volatility. The index has fallen ...

Nomura has a Buy rating on Cipla after the company's MD reassured that the competitiveness of the Indian generics biz won't ...

Mumbai: Cipla, an Indian multinational pharmaceutical company, has announced that the United States Food and Drugs ...

Mumbai: Pharma major, Cipla, has received final approval from the United States Food and Drug Administration (USFDA) for the New Drug Application (‘NDA’) submitted for ‘Nilotinib Capsules 50, ...

Cipla announced that it has received final approval from the United States Food and Drug Administration (USFDA) for the new drug application (NDA) submitted for 'Nilotinib Capsules 50, 150 and 200 mg' ...

Meanwhile, USFDA has conducted a current good manufacturing practices (cGMP) inspection at the analytical testing facility of Sitec Labs, wholly owned subsidiary of the Company (Sitec) located in ...

In a press release issued after market hours on February 20, Cipla announced that it has received approval for Nilotinib ...

The company has received final approval from the United States Food and Drug Administration (USFDA) for its New Drug ...

Nilotinib is an FDA approved drug used for the treatment of Philadelphia Chromosome Positive CML, which is a cancer of blood ...